Essa Pharma Inc Expected To Post A Loss Of 25 Cents A Share: Earnings Preview

ESSA Pharma

02/05/2022 18:48

* ESSA Pharma Inc  EPIX.OQ   EPIX.O  is expected to show no
change
in quarterly revenue when it reports  results on May 4
(estimated). 
    * ​Refinitiv's mean analyst estimate for ESSA Pharma Inc is
for a
loss of 25 cents per share. For the same quarter last year, the
company reported a loss of 36 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $40​, above​ its last closing price of $5.67. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.23       -0.23      -0.21     Beat    8.7
 Sep. 30 2021  -0.22       -0.23      -0.20     Beat    14
 Jun. 30 2021  -0.26       -0.26      -0.21     Beat    20​
 Mar. 31 2021  -0.21       -0.21      -0.36     Missed  -68.2
 ​​Dec.        -0.17       -0.17      -0.20     Missed  -17.6
 31 2020                                                
 Sep. 30 2020  -0.20       -0.19      -0.13     Beat    33.3​
 Jun. 30 2020  -0.29       -0.29      -0.24     Beat    18.2
 Mar. 31 2020  -0.22       -0.22      -0.45     Missed  -104.5
 This summary was machine generated May 2 at 17:48 GMT.  All
figures in US dollars  unless otherwise stated